As of Feb 27
| +0.01 / +0.38%|
The 5 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 3.00, with a high estimate of 7.50 and a low estimate of 2.00. The median estimate represents a +12.36% increase from the last price of 2.67.
The current consensus among 5 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.